Inventor

BELLDEGRUN ARIE S

US9 patents

⚠️ This page may combine multiple inventors who share the name “BELLDEGRUN ARIE S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV CALIFORNIA

6 patents

US5919652AJul 6, 1999

Nucleic acid molecules comprising the prostate specific antigen (PSA) promoter and uses thereof

UNIV CALIFORNIA51 citations91

US7267978B1Sep 11, 2007

Chimeric transcriptional regulatory element compositions and methods for increasing prostate-targeted gene expression

UNIV CALIFORNIA10 citations78

US9968664B2May 15, 2018

Fusion molecule based on novel TAA variant

UNIV CALIFORNIA1 citations61

US8378084B2Feb 19, 2013

Fusion molecule based on novel TAA variant

UNIV CALIFORNIA3 citations61

US6110702AAug 29, 2000

PSA positive regulating (PSAR) sequences and uses thereof

UNIV CALIFORNIA4 citations57

US10376567B2Aug 13, 2019

Fusion molecule based on TAA variant

UNIV CALIFORNIA0 citations51

JANSSEN ONCOLOGY INC

1 patent

US10702540B2Jul 7, 2020

Methods and compositions for treating cancer

JANSSEN ONCOLOGY INC0 citations37

BUI MATTHEW H T

1 patent

US8936914B2Jan 20, 2015

Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX

BUI MATTHEW H T0 citations35

BELLDEGRUN ARIE S

1 patent

US8778608B2Jul 15, 2014

CA9 gene single nucleotide polymorphisms predict prognosis and treatment response of metastatic renal cell carcinoma

BELLDEGRUN ARIE S0 citations34